Matti Vuoristo

1.8k total citations
50 papers, 1.4k citations indexed

About

Matti Vuoristo is a scholar working on Surgery, Epidemiology and Hepatology. According to data from OpenAlex, Matti Vuoristo has authored 50 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Surgery, 17 papers in Epidemiology and 14 papers in Hepatology. Recurrent topics in Matti Vuoristo's work include Cholesterol and Lipid Metabolism (15 papers), Liver Disease Diagnosis and Treatment (15 papers) and Liver Diseases and Immunity (11 papers). Matti Vuoristo is often cited by papers focused on Cholesterol and Lipid Metabolism (15 papers), Liver Disease Diagnosis and Treatment (15 papers) and Liver Diseases and Immunity (11 papers). Matti Vuoristo collaborates with scholars based in Finland, United States and Estonia. Matti Vuoristo's co-authors include Tatu A. Miettinen, T.A. Miettinen, Helena Gylling, Markku Nissinen, Martti Färkkilâ, K. Seppälä, Kati Hakala, Heikki Järvinen, Reijo S. Tilvis and Ville Valtonen and has published in prestigious journals such as Gastroenterology, American Journal of Clinical Nutrition and Hepatology.

In The Last Decade

Matti Vuoristo

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Vuoristo Finland 22 770 408 265 237 227 50 1.4k
G Budillon Italy 24 603 0.8× 508 1.2× 347 1.3× 95 0.4× 351 1.5× 100 1.7k
C.‐H. Florén Sweden 18 429 0.6× 296 0.7× 156 0.6× 234 1.0× 97 0.4× 47 996
F Miglio Italy 16 371 0.5× 534 1.3× 178 0.7× 241 1.0× 366 1.6× 63 1.2k
Dario Sorrentino Italy 23 499 0.6× 517 1.3× 449 1.7× 460 1.9× 105 0.5× 62 1.7k
C. N. Williams Canada 20 691 0.9× 846 2.1× 245 0.9× 586 2.5× 470 2.1× 55 2.0k
Matthew McKinley United States 20 758 1.0× 297 0.7× 192 0.7× 441 1.9× 48 0.2× 63 1.6k
Gourdas Choudhuri India 24 856 1.1× 614 1.5× 159 0.6× 208 0.9× 219 1.0× 82 1.7k
Alexandra Zahn Germany 17 435 0.6× 329 0.8× 467 1.8× 348 1.5× 162 0.7× 24 1.4k
Anne Myara France 22 505 0.7× 204 0.5× 547 2.1× 170 0.7× 272 1.2× 53 1.6k
Martin Leníček Czechia 20 334 0.4× 366 0.9× 490 1.8× 183 0.8× 153 0.7× 65 1.2k

Countries citing papers authored by Matti Vuoristo

Since Specialization
Citations

This map shows the geographic impact of Matti Vuoristo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Vuoristo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Vuoristo more than expected).

Fields of papers citing papers by Matti Vuoristo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Vuoristo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Vuoristo. The network helps show where Matti Vuoristo may publish in the future.

Co-authorship network of co-authors of Matti Vuoristo

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Vuoristo. A scholar is included among the top collaborators of Matti Vuoristo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Vuoristo. Matti Vuoristo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ebeling, Freja, Maija Lappalainen, Matti Vuoristo, et al.. (2001). Factors Predicting Interferon Treatment Response in Patients With Chronic Hepatitis C: Late Viral Clearance Does Not Preclude A Sustained Response. The American Journal of Gastroenterology. 96(4). 1237–1242. 18 indexed citations
2.
Miettinen, T A, Matti Vuoristo, Helena Gylling, A. B. Christophe, & An S. De Vriese. (2000). Plant sterols regulate absorption and serum levels of different sterols.. 276–286. 2 indexed citations
3.
Kisand, Kai, Kalle Kisand, Anna–Liisa Karvonen, et al.. (1998). Antibodies to pyruvate dehydrogenase in primary biliary cirrhosis: correlation with histology. Apmis. 106(7-12). 884–892. 17 indexed citations
4.
Miettinen, Tatu A., Tuula Kiviluoto, M. Taavitsainen, et al.. (1998). Cholesterol metabolism and serum and biliary noncholesterol sterols in gallstone patients during simvastatin and ursodeoxycholic acid treatments†. Hepatology. 27(3). 649–655. 21 indexed citations
5.
Collin, Pekka, Risto Julkunen, J. Lehtola, et al.. (1997). [Celiac disease, treatment guideline].. PubMed. 113(1). 82–7. 1 indexed citations
6.
Hakala, Kati, Matti Vuoristo, & T. A. Miettinen. (1996). Serum Cholestanol, Cholesterol Precursors and Plant Sterols in Different Inflammatory Bowel Diseases. Digestion. 57(2). 83–89. 11 indexed citations
7.
Gylling, Helena, Martti Färkkilâ, Matti Vuoristo, & Tatu A. Miettinen. (1995). Metabolism of cholesterol and low- and high-density lipoproteins in primary biliary cirrhosis: Cholesterol absorption and synthesis related to lipoprotein levels and their kinetics. Hepatology. 21(1). 89–95. 32 indexed citations
8.
Vuoristo, Matti & T.A. Miettinen. (1994). Absorption, metabolism, and serum concentrations of cholesterol in vegetarians: effects of cholesterol feeding. American Journal of Clinical Nutrition. 59(6). 1325–1331. 61 indexed citations
9.
Vuoristo, Matti, Y. Antero Kesäniemi, Helena Gylling, & T.A. Miettinen. (1993). Metabolism of cholesterol and apolipoprotein B in celiac disease. Metabolism. 42(11). 1386–1391. 15 indexed citations
10.
Vuoristo, Matti, Hannu Väänänen, & Tatu A. Miettinen. (1992). Cholesterol malabsorption in pancreatic insufficiency: Effects of enzyme substitution. Gastroenterology. 102(2). 647–655. 41 indexed citations
11.
Nuutinen, Hannu, Matti Vuoristo, Martti Färkkilâ, et al.. (1992). Hemorrhagic gastropathy in epidemic nephropathy. Gastrointestinal Endoscopy. 38(4). 476–480. 18 indexed citations
12.
Vuoristo, Matti, P Pikkarainen, I. Michael Samloff, et al.. (1991). Functional Characteristics of Duodenal Ulcer Patients and Their First-Degree Relatives. Scandinavian Journal of Gastroenterology. 26(sup186). 52–61. 3 indexed citations
13.
Välimäki, Matti, Georg Alfthan, Matti Vuoristo, & Reino Ylikahri. (1991). Effects of selenium supplementation on blood and urine selenium levels and liver function in patients with primary biliary cirrhosis. Clinica Chimica Acta. 196(1). 7–15. 9 indexed citations
14.
Kesäniemi, Y. Antero, M. Koskenvuo, Matti Vuoristo, & T.A. Miettinen. (1989). Biliary lipid composition in monozygotic and dizygotic pairs of twins.. Gut. 30(12). 1750–1756. 42 indexed citations
15.
Kesäniemi, Y. Antero, Martti Färkkilâ, Kari Kervinen, et al.. (1987). Regulation of low-density lipoprotein apolipoprotein B levels. American Heart Journal. 113(2). 508–513. 17 indexed citations
16.
Maury, C. P. J., A.-M. Teppo, Matti Vuoristo, Ulla Turunen, & Ismo Virtanen. (1986). Autoantibodies to gliadin-binding 90 kDa glycoprotein in coeliac disease.. Gut. 27(2). 147–152. 8 indexed citations
17.
Vuoristo, Matti & T.A. Miettinen. (1986). Serum cholesterol precursor sterols in coeliac disease: effects of gluten free diet and cholestyramine.. Gut. 27(11). 1312–1319. 31 indexed citations
18.
Kesäniemi, Y. Antero, Mikko Salaspuro, Matti Vuoristo, & T A Miettinen. (1982). Biliary lipid secretion in chronic cholestatic liver disease.. Gut. 23(11). 931–938. 11 indexed citations
19.
Mustajoki, Pertti, Matti Vuoristo, & Timo Reunala. (1981). Celiac disease or dermatitis herpetiformis in three patients with porphyria. Digestive Diseases and Sciences. 26(7). 618–621. 5 indexed citations
20.
Kurki, Pekka, Aaro Miettinen, Ewert Linder, et al.. (1980). Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance.. Gut. 21(10). 878–884. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G Budillon Breakdown of academic impact, for papers by C.‐H. Florén Breakdown of academic impact, for papers by F Miglio Breakdown of academic impact, for papers by Dario Sorrentino Breakdown of academic impact, for papers by C. N. Williams Breakdown of academic impact, for papers by Matthew McKinley Breakdown of academic impact, for papers by Gourdas Choudhuri Breakdown of academic impact, for papers by Alexandra Zahn Breakdown of academic impact, for papers by Anne Myara Breakdown of academic impact, for papers by Martin Leníček
Rankless by CCL
2026